The 12-month open-label extension of the PACIFIC trial demonstrated that bexicaserin significantly reduced seizure frequency ...
In this video interview, Michael Andreini, president and CEO of the Multiple Myeloma Research Foundation, discusses how MMRF ...
Recent survey study of 978 cancer patients and their relatives uncovered reasons behind their willingness, or lack thereof, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback